Researchers at Aarhus University have discovered a new method to activate the complement system using bispecific single-domain antibodies, termed BiCEs. These molecules can specifically target cancer cells and activate the complement system, leading to the killing of targeted cancer cells.
SourceAarhus University·JournalThe Journal of Immunology·TypeExperimental study·DateJun 23, 2023
Research has established Neowater's ability to refine the standard hybridoma production process, leading to enhanced yields of human monoclonal antibodies. The novel nanoparticle-doped water also stimulates new membrane formation, improving cell growth and proliferation rates.
SourceDo-Coop Technologies Ltd.·JournalBMC Biotechnology·DateFeb 14, 2008